SIMVASTATIN - A NEW HMG COA REDUCTASE INHIBITOR

被引：8

作者：

PIETRO, DA

MANTELL, G

机构：

[1] BROCKTON W ROXBURY VET ADM MED CTR,DEPT CARDIOL,BROCKTON,MA 02401

[2] HARVARD UNIV,SCH MED,BOSTON,MA 02115

[3] MERCK SHARP & DOHME LTD,CLIN RES,W POINT,PA 19486

来源：

CARDIOVASCULAR DRUG REVIEWS | 1990年 / 8卷 / 03期

关键词：

HMG CoA reductase; Hypercholesterolemia; Hyperlipidemia; Simvastatin;

D O I：

10.1111/j.1527-3466.1990.tb00394.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：220 / 228

页数：9

共 25 条

[1] MEVINOLIN - A HIGHLY POTENT COMPETITIVE INHIBITOR OF HYDROXYMETHYLGLUTARYL-COENZYME-A REDUCTASE AND A CHOLESTEROL-LOWERING AGENT [J].

ALBERTS, AW ;

CHEN, J ;

KURON, G ;

HUNT, V ;

HUFF, J ;

HOFFMAN, C ;

ROTHROCK, J ;

LOPEZ, M ;

JOSHUA, H ;

HARRIS, E ;

PATCHETT, A ;

MONAGHAN, R ;

CURRIE, S ;

STAPLEY, E ;

ALBERSSCHONBERG, G ;

HENSENS, O ;

HIRSHFIELD, J ;

HOOGSTEEN, K ;

LIESCH, J ;

SPRINGER, J .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (07) :3957-3961

[2]

ALBERTS AW, 1986, 9TH INT S DRUGS AFF, P8

[3] SIMVASTATIN, A COMPETITIVE INHIBITOR OF HMG-COA REDUCTASE, LOWERS CHOLESTEROL SATURATION INDEX OF GALLBLADDER BILE [J].

DUANE, WC ;

HUNNINGHAKE, DB ;

FREEMAN, ML ;

POOLER, PA ;

SCHLASNER, LA ;

GEBHARD, RL .

HEPATOLOGY, 1988, 8 (05) :1147-1150

[4]

DUGGAN DE, 1989, DRUG METAB DISPOS, V17, P166

[5] COMPETITIVE INHIBITION OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE BY ML-236A AND ML-236B FUNGAL METABOLITES, HAVING HYPOCHOLESTEROLEMIC ACTIVITY [J].

ENDO, A ;

KURODA, M ;

TANZAWA, K .

FEBS LETTERS, 1976, 72 (02) :323-326

[6] HELSINKI HEART-STUDY - PRIMARY-PREVENTION TRIAL WITH GEMFIBROZIL IN MIDDLE-AGED MEN WITH DYSLIPIDEMIA - SAFETY OF TREATMENT, CHANGES IN RISK-FACTORS, AND INCIDENCE OF CORONARY HEART-DISEASE [J].

FRICK, MH ;

ELO, O ;

HAAPA, K ;

HEINONEN, OP ;

HEINSALMI, P ;

HELO, P ;

HUTTUNEN, JK ;

KAITANIEMI, P ;

KOSKINEN, P ;

MANNINEN, V ;

MAENPAA, H ;

MALKONEN, M ;

MANTTARI, M ;

NOROLA, S ;

PASTERNACK, A ;

PIKKARAINEN, J ;

ROMO, M ;

SJOBLOM, T ;

NIKKILA, EA .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (20) :1237-1245

[7] TISSUE SELECTIVITY OF THE CHOLESTEROL-LOWERING AGENTS LOVASTATIN, SIMVASTATIN AND PRAVASTATIN IN RATS INVIVO [J].

GERMERSHAUSEN, JI ;

HUNT, VM ;

BOSTEDOR, RG ;

BAILEY, PJ ;

KARKAS, JD ;

ALBERTS, AW .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 158 (03) :667-675

[8] ANIMAL SAFETY AND TOXICOLOGY OF SIMVASTATIN AND RELATED HYDROXY-METHYLGLUTARYL-COENZYME-A REDUCTASE INHIBITORS [J].

GERSON, RJ ;

MACDONALD, JS ;

ALBERTS, AW ;

KORNBRUST, DJ ;

MAJKA, JA ;

STUBBS, RJ ;

BOKELMAN, DL .

AMERICAN JOURNAL OF MEDICINE, 1989, 87 (4A) :S28-S38

[9] ON THE ETIOLOGY OF SUBCAPSULAR LENTICULAR OPACITIES PRODUCED IN DOGS RECEIVING HMG-COA REDUCTASE INHIBITORS [J].

GERSON, RJ ;

MACDONALD, JS ;

ALBERTS, AW ;

CHEN, J ;

YUDKOVITZ, JB ;

GREENSPAN, MD ;

RUBIN, LF ;

BOKELMAN, DL .

EXPERIMENTAL EYE RESEARCH, 1990, 50 (01) :65-78

[10] LOVASTATIN (MEVINOLIN) IN THE TREATMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA - A MULTICENTER STUDY [J].

HAVEL, RJ ;

HUNNINGHAKE, DB ;

ILLINGWORTH, DR ;

LEES, RS ;

STEIN, EA ;

TOBERT, JA ;

BACON, SR ;

BOLOGNESE, JA ;

FROST, PH ;

LAMKIN, GE ;

LEES, AM ;

LEON, AS ;

GARDNER, K ;

JOHNSON, G ;

MELLIES, MJ ;

RHYMER, PA ;

TUN, P .

ANNALS OF INTERNAL MEDICINE, 1987, 107 (05) :609-615

← 1 2 3 →